Compare Shreyas Interm. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 2.68% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -7.74 times
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 43 Cr (Micro Cap)
NA (Loss Making)
22
0.00%
0.51
-8.27%
2.85
Total Returns (Price + Dividend) 
Shreyas Interm. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Shreyas Intermediates Ltd is Rated Strong Sell
Shreyas Intermediates Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Jan 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 16 July 2026, providing investors with an up-to-date view of the company’s position.
Read full news article
Shreyas Intermediates Ltd is Rated Strong Sell
Shreyas Intermediates Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 01 July 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
10-Jul-2026 | Source : BSESbmission of Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations 2018 for the quarter ended 30.06.2026
Closure of Trading Window
29-Jun-2026 | Source : BSEPursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Shreyas Intermediates Limiteds Code of conduct for Insiders the Trading Window for dealing in securities of the company shall remain closed for Designated Persons (as defined in the Code) including their immediate relatives with effect from 01st July 2026 till 48 hours after the announcement of the Un-Audited Financial Results of the Company for the quarter ended 30.06.2026.
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEPursuent the Regulation 24(A) of the SEBI LODR Regulations2015 we enclosed herewith the Secretrial Compliance Report duly issued by Mr. Pankaj Desai PCS for the Financial Year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
10.028
Held by 3 Schemes (0.0%)
Held by 1 FIIs (8.39%)
Kesar Petroproducts Limited (27.59%)
Krish Pharma Speciality Private Limited- Escrow Demat Accoun (24.7%)
7.83%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 28.21% vs -62.50% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 23.62% vs 11.81% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 20.75% vs -0.63% in Mar 2025







